EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Prognostic performance of Hong Kong Liver Cancer with Barcelona Clinic Liver Cancer staging systems in hepatocellular carcinoma

Mohamed Kohla, Reham Ashour, Hossam Taha, Osama El-Abd, Maher Osman, Mai Abozeid, Sally Waheed ELKhadry

BMC Gastroenterology · 2024

DOI: 10.1186/s12876-024-03387-5 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift BMC Gastroenterology, 2024. Verfasst von Mohamed Kohla und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebin El-Kom, 32511, Egypt. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Staging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minufiya University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accurate staging is necessary for predicting hepatocellular carcinoma (HCC) prognosis and guiding patient management. The Barcelona Clinic Liver Cancer (BCLC) staging system has limitations due to heterogeneity observed among patients in BCLC stages B and C. In contrast, the Hong Kong Liver Cancer (HKLC) staging system offers more aggressive treatment strategies.

Aim

To compare the prognostic performance of HKLC and BCLC staging systems in Egyptian patients with HCC.

Methods

We conducted a retrospective study at the National Liver Institute, Menoufia University, Egypt, on 1015 HCC patients. Data was collected from patients’ medical records over 10 years (from 2008 to 2018). The BCLC and HKLC stages were identified, and Kaplan-Meier survival analysis was used to compare patients’ overall survival rates within each staging system. Additionally, we evaluated the comparative prognostic performance of the two staging systems.

Results

Hepatitis C was identified as the underlying etiology in 799 patients (78.7%), hepatitis B in 12 patients (1.2%), and non-viral causes in 204 patients (20.1%). The survival analysis demonstrated significant differences across the various stages within both the BCLC and HKLC systems. The receiver operating characteristic (ROC) curves indicated a marginally superior performance of the HKLC system in predicting survival at 1, 2, and 3 years compared to the BCLC system. Furthermore, the HKLC staging provided a slightly enhanced prognostic capability, particularly for patients classified under BCLC stages B and C, suggesting a potential survival benefit.

Conclusion

HKLC classification had a slightly better prognostic performance than BCLC staging system and may offer a survival advantage for certain patients with HCC in BCLC stage B and C HCC cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsNeoplasm StagingHumansFemaleMaleRetrospective StudiesMiddle AgedPrognosisKaplan-Meier EstimateEgyptAgedAdultSurvival RateROC Curve

Stichwörter der Autor:innen

Barcelona Clinic Liver CancerEgyptHepatocellular carcinomaHong Kong Liver CancerPrognostic performanceStaging systems

Autor:innen und Institutionen

  • Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebin El-Kom, 32511, Egypt.
  • Department of Diagnostic Medical Imaging and Interventional Radiology, National Liver Institute, Menoufia University, Shebin El-Kom, 32511, Egypt.
  • Department of Hepatopancreatobiliary surgery, National Liver Institute, Menoufia University, Shebin El-Kom, 32511, Egypt.
  • Department of Epidemiology and Preventive Medicine, National Liver Institute, Menoufia University, Shebin El-Kom, 32511, Egypt. drsallywaheed@liver.menofia.edu.eg.

Förderung

  • Minufiya University

Zitieren

APA

Kohla, M., Ashour, R., Taha, H., El-Abd, O., Osman, M., Abozeid, M., & ELKhadry, S. W. (2024). Prognostic performance of Hong Kong Liver Cancer with Barcelona Clinic Liver Cancer staging systems in hepatocellular carcinoma. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03387-5

Vancouver

Kohla M, Ashour R, Taha H, El-Abd O, Osman M, Abozeid M, et al. Prognostic performance of Hong Kong Liver Cancer with Barcelona Clinic Liver Cancer staging systems in hepatocellular carcinoma. BMC Gastroenterology. 2024. doi:10.1186/s12876-024-03387-5

BibTeX
@article{Kohla2024,
  author = {Kohla, Mohamed and Ashour, Reham and Taha, Hossam and El-Abd, Osama and Osman, Maher and Abozeid, Mai and ELKhadry, Sally Waheed},
  title = {Prognostic performance of Hong Kong Liver Cancer with Barcelona Clinic Liver Cancer staging systems in hepatocellular carcinoma},
  journal = {BMC Gastroenterology},
  year = {2024},
  doi = {10.1186/s12876-024-03387-5}
}
Kostenlos starten →